Board & Team

Barbara Bierer, MD, is Professor of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston and a hematologist/oncologist. She is the faculty co-chair of the Multi-Regional Clinical Trials Center at Harvard University (Harvard MRCT), a study center whose purpose is to improve the ethical, logistical and regulatory aspects of international clinical trials, with a special focus on the emerging economies, and the Director of the Regulatory Foundations, Ethics and the Law Program of the Harvard clinical and translational sciences center....

Charles J. Dockendorff

Former Executive Vice President and Chief Financial Officer for Covidien, a publicly traded medical device and supplies company, Charles J. Dockendorff was responsible for the company’s global financial management activities, including Corporate Accounting, Tax, Treasury, Financial Planning and Investor Relations, as well as Internal Audit and Information Services....

Lawrence K. Fish

Board Chair

Lawrence K. Fish is the former Chairman and CEO of Citizens Financial Group, Inc., a multi-state commercial bank holding company headquartered in Providence, Rhode Island. During his 17-year tenure, CFG grew 30-fold and became one of the 10 largest commercial bank holding companies in the United States in total assets and deposits. It operates its branch network in 13 states through its Citizens Bank and Charter One brands, and has non-branch retail and commercial offices in about 40 states....

Robert E. Hallagan

Robert E. Hallagan is Vice Chairman and Co-Leader for the Board Leadership Services Practice at Korn Ferry, the world’s largest talent management firm, with 80 offices worldwide. He is a recognized expert in Board Governance and has a strong record of identifying and securing top talent for a wide range of clients whom he advises on Board and CEO issues. In 1996 he co-founded The Center for Board Leadership, a joint venture with The National Association of Corporate Directors. He served as the Center’s CEO and then Chairman, leading its mission of developing “Best Practices for Effective Board Leadership.”

John Isaacson

John Isaacson founded Isaacson, Miller in 1982. Isaacson was diverted from his natural career in his twenties by an academic and civic engagement, which took him to Dartmouth for a BA; to Oxford University on a Rhodes Scholarship for a BA/MA in Philosophy, Politics, and Economics; and to Harvard Law School. Following law school, he chose a career in public service....

Katherine Luzuriaga

Katherine Luzuriaga, MD, is the UMass Memorial Health Care Chair in Biomedical Research, Professor of Molecular Medicine, and Vice Provost for Clinical and Translational Research at the University of Massachusetts Medical School (UMMS). She is a pediatric infectious disease physician, whose research has led to the development of new prevention and treatment strategies for pediatric HIV-1 infection and informed global treatment guidelines and policies. As Director of the UMass Center for Clinical and Translational Science, Dr. Luzuriaga leads efforts to translate scientific discoveries into products and approaches that improve individual and population health.

Latanya Mapp Frett

Latanya Mapp Frett is President and CEO of Global Fund for Women. Previously, she was the Executive Director of Planned Parenthood Global, the international arm of Planned Parenthood Federation of America, with regional and country offices in Africa and Latin America. She quadrupled the size of the program in four years to become one of the most innovative and sustainable global health organizations in the field. Prior to joining Planned Parenthood Global, Frett worked with USAID for 10 years, including as Mission Director in Nigeria and Assistant Director in Mali...

John H. Masterson

John H. Masterson is the former Senior Vice President and General Counsel of Covidien, a publicly traded medical device and supply company that was acquired by Medtronic, Inc., in 2015. In this position, he was responsible for all legal and government affairs relating to Covidien’s businesses, including providing legal advice to senior management on business and commercial issues, overseeing litigation matters, leading mergers and acquisitions, and managing FDA/regulatory legal issues and international matters...

W. Gyude Moore

W. Gyude Moore is a visiting fellow at the Center for Global Development. He previously served as Liberia’s Minister of Public Works with oversight over the construction and maintenance of public infrastructure from December 2014 to January 2018. Prior to that role, Moore served as Deputy Chief of Staff to President Ellen Johnson-Sirleaf and Head of the President’s Delivery Unit (PDU). As Head of the PDU, his team monitored progress and drove delivery of the Public Sector Investment Program of Liberia—a program of over $1 billion in road, power, port infrastructure, and social programs in Liberia after the civil war...

Bernard Nahlen

Bernard Nahlen, MD, is Director of the University of Notre Dame’s Eck Institute for Global Health and comes to MSH with decades of experience in research and disease elimination programs around the world. Prior to his recent appointment as Director of the University of Notre Dame’s Eck Institute for Global Health, Dr. Nahlen served as Deputy Coordinator of the U.S. President’s Malaria Initiative (PMI) from 2007 to 2017. From 2005 to 2006, Dr. Nahlen was Senior Advisor, Monitoring and Evaluation, at the Global Fund to Fight AIDS, Tuberculosis and Malaria....

Dan Pellegrom

Dan Pellegrom’s career in reproductive health spanned more than 4 decades including Presidencies of three different organizations, concluded with a 26 year tenure as President and CEO of Pathfinder International. Pellegrom is widely respected for his experience in both management and advocacy....

Francis Aboagye-Nyame

Program Director, MTaPS Program; Practice Area Lead, Pharmaceutical Systems Strengthening

Francis Aboagye-Nyame provides strategic vision and leadership to the $169 million, USAID-funded Medicines, Technologies and Pharmaceutical Systems (MTaPS) program, collaborating closely with USAID, country governments, implementing agencies, and partners on pharmaceutical systems strengthening activities to meet its goals. A thought leader on pharmaceutical management with over 25 years of experience...

Gordon Comstock

Vice President, Program Delivery Group

Gordon Comstock is the Vice President of the Program Delivery Group at MSH, where he is responsible for MSH’s global portfolio of health care programs and people; shaping and overseeing program execution; and managing all country operations to support the achievement of MSH’s mission, goals, and objectives...

Matthew Gemeda

Senior Director of Internal Audit

Matthew Gemeda is the Senior Director of Internal Audit at MSH and supports the Leadership Team, MSH business units and projects on audits, internal controls, business processes and compliance matters. He serves as the liaison to the audit committee of the Board of Directors and provides technical support and leadership to compliance officers in projects across all MSH offices...

David Humphries

Chief External Affairs Officer

David Humphries is Chief External Affairs Officer at Management Sciences for Health. Since 2000, Humphries has led strategic communications and government relations teams, and has led communications strategies in countries across Europe, Latin America, Africa, the Middle East and Asia in the nonprofit, government and private sector....

Daniel H. Kress

Vice President for Global Health Systems Innovation

Daniel H. Kress, PhD, is the Vice President for Global Health Systems Innovation at MSH, which is the team responsible for the organization’s global and strategic technical expertise. A health economist by background, Kress has three decades of experience in health systems, health reform, and evaluation. His experience includes working in more than 30 countries...

Colleen McGuffin

Chief People and Culture Officer

Colleen McGuffin is Chief People and Culture Officer of MSH. McGuffin has extensive leadership and culture-shaping experience from a diversity of global roles. Most recently, she served in various Vice President roles at Merck & Co, one of the largest pharmaceutical companies in the world. McGuffin’s roles at Merck span over a decade in customer engagement, marketing, vaccine strategy, in addition to global medical and policy affairs...

Craig Molyneaux

Chief Financial Officer

Craig Molyneaux is Chief Financial Officer of MSH, where he plays a broad and strategic leadership role in the organization’s overall growth and development. He serves as financial advisor and partner to the CEO, leadership team, the board of directors and its audit and finance committees on matters relating to financial status, risk management, and long-term planning...

Dana Sandstrom Keating

Vice President, Strategy, Business Development & Partnerships

Dana Sandstrom Keating is the Vice President of Strategy, Business Development & Partnerships at Management Sciences for Health. She leads MSH’s donor engagement and strategic partnership efforts across all areas of the organization’s work...

Ersin Topcuoglu

Program Director, Health Systems for Tuberculosis

Ersin Topcuoglu, MD, MPH, Program Director for the MSH-led USAID Health Systems for Tuberculosis (HS4TB) program, has more than 30 years of public health experience in designing, leading, and managing complex international health programs...

Marian W. Wentworth

President and Chief Executive Officer

Marian W. Wentworth is President and Chief Executive Officer of MSH. A leader in managing complex international public health initiatives globally and across diverse cultures, Wentworth uses her private sector and nonprofit acumen to address global health challenges from new vantage points. Since 2017, she has helped MSH make highly effective, sustainable systemic improvements in some of the globe’s most challenging environments...

Paul M. Zimmerman

General Counsel

Paul M. Zimmerman is the General Counsel at MSH, providing legal advice and oversight to ensure that MSH operates according to the law and in the best interest of all stakeholders. Prior to joining MSH, he served as General Counsel, Chief Legal Officer, and Chief Ethics Officer at the Inter-American Foundation in Washington, DC...